MedPath

Evaluating the combined use of non-invasive respiratory support alongside preventative anticonvulsant treatment in children presenting to hospital with cerebral malaria and convulsions

Phase 1
Recruiting
Conditions
Malaria
Registration Number
PACTR202112749708968
Lead Sponsor
Imperial College London
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1.Aged 3 months to 12-years
2.Hospitalised with:
2.1.Current or recent evidence of P. falciparum malaria (slide or rapid diagnostic test (RDT) positive)
2.2.Blantyre Coma Score 2 or less that persists even after correction for concurrent hypoglycaemia (defined as blood glucose <3 mmol/L)
2.3.History of seizures in this illness

Exclusion Criteria

1.Known cerebral palsy or significant neuro-development delay (which will affect endpoint assessment)
2.Skin disease or burns preventing use of the BCV
3.Respiratory or cardio-respiratory arrest prior to enrolment
4.A comorbidity which clinician believes has a significant risk of poor outcome e.g. malignancy, end-stage renal failure, major cardiac condition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.